Evidence map›Paper›PMID 29678984›Full record

ArticleBMJ open2018

Validating malignant melanoma ICD-9-CM codes in Umbria, ASL Napoli 3 Sud and Friuli Venezia Giulia administrative healthcare databases: a diagnostic accuracy study.

Massimiliano Orso, Diego Serraino, Iosief Abraha, Mario Fusco, Gianni Giovannini, Paola Casucci, Francesco Cozzolino, Annalisa Granata, Michele Gobbato, Fabrizio Stracci and 7 more

Abstract readValidation Study
In one paragraph

Article in BMJ open, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Massimiliano OrsoHealth Planning Service, Regional Health Authority of Umbria, Perugia, Italy.
Diego SerrainoCancer Epidemiology Unit, Centro di Riferimento Oncologico Aviano, Aviano, Italy.
Iosief AbrahaHealth Planning Service, Regional Health Authority of Umbria, Perugia, Italy.ORCID 0000-0002-5440-775X
Mario FuscoRegistro Tumori Regione Campania, ASL Napoli 3 Sud, Brusciano, Italy.
Gianni GiovanniniHealth Planning Service, Regional Health Authority of Umbria, Perugia, Italy.
Paola CasucciSOC Epidemiologia Oncologica, Centro di Riferimento Oncologico Aviano, Aviano, Italy.
Francesco CozzolinoHealth Planning Service, Regional Health Authority of Umbria, Perugia, Italy.
Annalisa GranataRegistro Tumori Regione Campania, ASL Napoli 3 Sud, Brusciano, Italy.
Michele GobbatoSOC Epidemiologia Oncologica, Centro di Riferimento Oncologico Aviano, Aviano, Italy.
Fabrizio StracciPublic Health Department, University of Perugia, Perugia, Italy.
Valerio CiulloRegistro Tumori Regione Campania, ASL Napoli 3 Sud, Brusciano, Italy.
Maria Francesca VitaleRegistro Tumori Regione Campania, ASL Napoli 3 Sud, Brusciano, Italy.
Paolo EusebiHealth Planning Service, Regional Health Authority of Umbria, Perugia, Italy.ORCID 0000-0002-0715-6396
Walter OrlandiDirezione Regionale Salute, Regional Health Authority of Umbria, Perugia, Italy.
Alessandro MontedoriHealth Planning Service, Regional Health Authority of Umbria, Perugia, Italy.
Ettore BidoliCancer Epidemiology Unit, Centro di Riferimento Oncologico Aviano, Aviano, Italy.
D.I.V.O. Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo assess the accuracy of International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) codes in identifying subjects with melanoma.

designA diagnostic accuracy study comparing melanoma ICD-9-CM codes (index test) with medical chart (reference standard). Case ascertainment was based on neoplastic lesion of the skin and a histological diagnosis from a primary or metastatic site positive for melanoma.

settingAdministrative databases from Umbria Region, Azienda Sanitaria Locale (ASL) Napoli 3 Sud (NA) and Friuli Venezia Giulia (FVG) Region.

participants112, 130 and 130 cases (subjects with melanoma) were randomly selected from Umbria, NA and FVG, respectively; 94 non-cases (subjects without melanoma) were randomly selected from each unit. OUTCOME MEASURES: Sensitivity and specificity for ICD-9-CM code 172.x located in primary position.

resultsThe most common melanoma subtype was malignant melanoma of skin of trunk, except scrotum (ICD-9-CM code: 172.5), followed by malignant melanoma of skin of lower limb, including hip (ICD-9-CM code: 172.7). The mean age of the patients ranged from 60 to 61 years. Most of the diagnoses were performed in surgical departments.The sensitivities were 100% (95% CI 96% to 100%) for Umbria, 99% (95% CI 94% to 100%) for NA and 98% (95% CI 93% to 100%) for FVG. The specificities were 88% (95% CI 80% to 93%) for Umbria, 77% (95% CI 69% to 85%) for NA and 79% (95% CI 71% to 86%) for FVG.

conclusionsThe case definition for melanoma based on clinical or instrumental diagnosis, confirmed by histological examination, showed excellent sensitivities and good specificities in the three operative units. Administrative databases from the three operative units can be used for epidemiological and outcome research of melanoma.

Indexed as

International Classification of DiseasesAdultDatabases, FactualDelivery of Health CareFemaleHumansItalyMaleMelanomaMiddle AgedSkin Neoplasmsaccuracyadministrative databaseIcd-9-cmmelanomasensitivity and specificityvalidity

Identifiers

PMID29678984
PMCPMC5914898

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.